These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15228494)

  • 21. Tuberculosis: current trends in diagnosis and treatment.
    Bello AK; Njoku CH
    Niger J Clin Pract; 2005 Dec; 8(2):118-24. PubMed ID: 16477867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy and diagnosis of tuberculosis.
    Saltini C
    Respir Med; 2006 Dec; 100(12):2085-97. PubMed ID: 17113007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New drugs for tuberculosis: current status and future prospects.
    O'Brien RJ; Spigelman M
    Clin Chest Med; 2005 Jun; 26(2):327-40, vii. PubMed ID: 15837114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan].
    Yamada N; Nagai H
    Kekkaku; 2009 Apr; 84(4):203-11. PubMed ID: 19425395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of tuberculosis: present status and future prospects.
    Onyebujoh P; Zumla A; Ribeiro I; Rustomjee R; Mwaba P; Gomes M; Grange JM
    Bull World Health Organ; 2005 Nov; 83(11):857-65. PubMed ID: 16302043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug resistance in tuberculosis].
    Winje BA; Mannsåker T; Langeland N; Heldal E
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2588-92. PubMed ID: 19023372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug abuse profile - patient delay, diagnosis delay and drug resistance pattern - among addict patients with tuberculosis.
    Shamaei M; Marjani M; Baghaei P; Chitsaz E; Rezaei Tabar E; Abrishami Z; Tabarsi P; Mansouri D; Masjedi MR
    Int J STD AIDS; 2009 May; 20(5):320-3. PubMed ID: 19386968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HIV and tuberculosis: new perspectives for diagnosis and treatment].
    Zellweger JP
    Rev Med Suisse; 2006 Nov; 2(87):2616-9. PubMed ID: 17343152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global epidemiology of tuberculosis: prospects for control.
    Lönnroth K; Raviglione M
    Semin Respir Crit Care Med; 2008 Oct; 29(5):481-91. PubMed ID: 18810682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis, a re-emergent disease.
    Valadas E; Antunes F
    Eur J Radiol; 2005 Aug; 55(2):154-7. PubMed ID: 15905058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa.
    Dong K; Thabethe Z; Hurtado R; Sibaya T; Dlwati H; Walker B; Wilson D
    J Infect Dis; 2007 Dec; 196 Suppl 3():S491-6. PubMed ID: 18181699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
    Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
    PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creation of a tuberculosis directly observed therapy provider network in New York City: a new model of public health.
    Klein SJ; Naizby BE
    J Public Health Manag Pract; 1995; 1(4):1-6. PubMed ID: 10186633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.